Astle Christopher has filed 11 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 10500 shares of Zymeworks Inc. ($ZYME) on January 05, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2024 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | M | Common Stock | 10500 | $0.00 | 12,497.0000 | 68,863,010 | 525.79% | 0.02% |
| Jan. 5, 2024 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | S | Common Stock | 4563 | $10.65 | 7,934.0000 | 68,863,010 | 36.51% | 0.01% |
| Jan. 8, 2024 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | S | Common Stock | 1431 | $11.22 | 6,503.0000 | 68,863,010 | 18.04% | 0.00% |
| Jan. 5, 2024 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | M | Restricted Stock Unit | 10500 | $0.00 | 21,000.0000 | 68,863,010 | 33.33% | 0.02% |
| Jan. 5, 2024 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 68,863,010 | 9999.99% | 0.07% |
| Jan. 5, 2024 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | A | Restricted Stock Unit | 30000 | $0.00 | 30,000.0000 | 68,863,010 | 9999.99% | 0.04% |
| Dec. 11, 2023 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | M | Common Stock | 1550 | $0.00 | 2,883.0000 | 65,249,184 | 116.28% | 0.00% |
| Dec. 11, 2023 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | S | Common Stock | 886 | $9.13 | 1,997.0000 | 65,249,184 | 30.73% | 0.00% |
| Dec. 11, 2023 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | M | Restricted Stock Unit | 1550 | $0.00 | 0.0000 | 65,249,184 | 100.00% | 0.00% |
| Jan. 5, 2023 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | A | Stock Option (Right to Buy) | 47000 | $0.00 | 47,000.0000 | 65,249,184 | 9999.99% | 0.07% |
| Jan. 5, 2023 | Zymeworks Inc. | $ZYME | Astle Christopher | SVP & Chief Financial Officer | A | Restricted Stock Unit | 31500 | $0.00 | 31,500.0000 | 65,249,184 | 9999.99% | 0.05% |